F. Collin

发表

Exploiting bacterial DNA gyrase as a drug target: current state and perspectives

A. Maxwell, F. Collin, Shantanu Karkare, 2011, Applied Microbiology and Biotechnology.

Synthesis of full length and truncated microcin B17 analogues as DNA gyrase poisons.

K. Jolliffe, R. Payne, A. Maxwell, 2014, Organic & biomolecular chemistry.

Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses

Anthony Maxwell, Amadeu Llebaria, Amit Gandhi, 2018, Cell.

The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action

N. Lall, S. Greive, A. Maxwell, 2012, The Journal of Biological Chemistry.

A β-hairpin is a minimal latch that supports positive supercoiling by reverse gyrase.

D. Klostermeier, F. Collin, Marine Weisslocker-Schaetzel, 2020, Journal of molecular biology.

The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents

A. Maxwell, F. Collin, 2019, Journal of molecular biology.

Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons

K. Jolliffe, R. Payne, A. Maxwell, 2013, PloS one.

Fragments of microcin B17 as a source of new topoisomerase inhibitors

F. Collin, 2010 .

The in-vivo activity of co-amoxiclav with netilmicin against experimental methicillin and gentamicin resistant Staphylococcus epidermidis infection in rabbits.

F. Collin, H. Portier, P. Chavanet, 1993, Journal of Antimicrobial Chemotherapy.

Lead selection and characterization of antitubercular compounds using the Nested Chemical Library.

G. Kéri, S. Cole, V. Nagaraja, 2015, Tuberculosis.